Pleural Mesothelioma (Evidence Based Management-6) Clinical Trials: Participation in clinical trials is encouraged for patients with pleural mesothelioma, as it offers access to investigational treatments and contributes to the advancement of knowledge and treatment options for the disease. Clinical trials may evaluate new drugs, treatment combinations, or innovative approaches such as immunotherapy or gene therapy.
Category: Physiotherapy
Pleural Mesothelioma (Evidence Based Management-5) Radiation Therapy: Radiation therapy may be used as part of multimodal treatment approaches for pleural mesothelioma, either before or after surgery, or as palliative therapy to alleviate symptoms and improve quality of life. Techniques such as intensity-modulated radiation therapy (IMRT) or stereotactic body radiation therapy (SBRT) may be employed to […]
Pleural Mesothelioma (Evidence Based Management-4) Systemic Therapy: Chemotherapy and, in some cases, targeted therapy or immunotherapy may be recommended for patients with advanced or unresectable pleural mesothelioma. Evidence-based chemotherapy regimens may include combinations of pemetrexed and platinum-based drugs, such as cisplatin or carboplatin.
Pleural Mesothelioma (Evidence based management – 3) Surgical Intervention: Surgery may be considered for certain patients with early-stage pleural mesothelioma who are candidates for curative-intent treatment. Surgical options may include extra pleural pneumonectomy (EPP), pleurectomy/decortication (P/D), or cytoreductive surgery with intrapleural chemotherapy.
Pleural Mesothelioma (Evidence Based Management-2) Multidisciplinary Evaluation: Treatment planning for pleural mesothelioma should involve a multidisciplinary team of specialists, including thoracic surgeons, medical oncologists, radiation oncologists, pulmonologists, pathologists, radiologists, and supportive care providers. This collaborative approach ensures that patients receive comprehensive and individualized care.